Patent · US Expired

Methods and compositions utilizing quinazolinones

US7105668B1 · kind B1 · utility

30Cited by
80References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 28, 2000
Grant dateSep 12, 2006
Priority date
Expiry dateFeb 10, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D239/91
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.